GATA4 and hepatocellular carcinoma: Given the facts that GATA4 is almost ubiquitously deficient in HCC patients and that several highly efficient systems for delivering genes for overexpression in tumor nodules are under development or clinical trial35, 36, our current finding is of paramount translational importance.